U.S. drug regulators on Dec. 8 announced emergency clearance for two COVID-19 vaccines for children as young as 6 months of age.
The updated vaccines from Pfizer and Moderna are now able to be administered to younger children after previously only being available to those 5 years of age and older, the U.S. Food and Drug Administration (FDA) said.